Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Keyword
-
- Accredited investor (2)
- Secondary markets (2)
- Securities law (2)
- Affordable Care Act (1)
- Corporate law (1)
-
- Corporations (1)
- Diversification (1)
- Financing (1)
- General advertising (1)
- Health care (1)
- Hedge funds (1)
- Investment (1)
- JOBS Act (1)
- Liquidity (1)
- Marketing (1)
- National Federation ofIndependent Business v. Sebelius (1)
- Obamacare (1)
- Private companies (1)
- Private equity (1)
- Private offering (1)
- Regulation D (1)
- Rule 506 (1)
- SEC (1)
- Safe harbor (1)
- Securities act (1)
- Securities and Exchange Commission (1)
- Securities exchange commission (1)
- Self-certification (1)
- Solicitation (1)
- Start-ups (1)
Articles 1 - 4 of 4
Full-Text Articles in Securities Law
In Search Of Safe Harbor: Suggestions For The New Rule 506(C), Usha Rodrigues
In Search Of Safe Harbor: Suggestions For The New Rule 506(C), Usha Rodrigues
Scholarly Works
I devote most of this essay to exploring how, exactly, the Securities and Exchange Commission (“SEC”) should go about providing guidelines to implement the statutory requirement that issuers have a reasonable belief that a purchaser is accredited. The SEC has proposed rules, but these rules merely restate what Congress has already required, thus sidestepping Congress’s direction that the agency itself articulate some verification methods. Taking the SEC’s decidedly amorphous proposal to task, I recommend that the SEC offer two nonexclusive safe harbors for issuers to guide them in determining whether a natural person is an accredited investor. The paragraphs below …
Securities Law's Dirty Little Secret, Usha Rodrigues
Securities Law's Dirty Little Secret, Usha Rodrigues
Scholarly Works
Securities law’s dirty little secret is that rich investors have access to special kinds of investments—hedge funds, private equity, private companies—that everyone else does not. This disparity stems from the fact that, from its inception, federal securities law has jealously guarded the manner in which firms can sell shares to the general public. Perhaps paternalistically, the law assumes that the average investor needs the protection of the full panoply of securities regulation and thus should be limited to buying public securities. In contrast, accredited—i.e., wealthy— investors, who it is presumed can fend for themselves, have the luxury of choosing between …
Is The Corporate Director's Duty Of Care A "Fiduciary' Duty? Does It Matter?, Christopher M. Bruner
Is The Corporate Director's Duty Of Care A "Fiduciary' Duty? Does It Matter?, Christopher M. Bruner
Scholarly Works
While reference to "fiduciary duties" (plural) is routinely employed in the United States as a convenient short-hand for a corporate director's duties of care and loyalty, other common-law countries generally treat loyalty as the sole "fiduciary duty." This contrast prompts some important questions about the doctrinal structure for duty of care analysis adopted in Delaware, the principal jurisdiction of incorporation for U.S. public companies. Specifically, has the evolution of Delaware's convoluted and problematic framework for evaluating disinterested board conduct been facilitated by styling care a "fiduciary" duty? If so, then how should Delaware lawmakers and judges respond moving forward?
In …
Employers United: An Empirical Analysis Of Corporate Political Speech In The Wake Of The Affordable Care Act, Elizabeth Weeks Leonard, Susan Scholz, Raquel Meyer Alexander
Employers United: An Empirical Analysis Of Corporate Political Speech In The Wake Of The Affordable Care Act, Elizabeth Weeks Leonard, Susan Scholz, Raquel Meyer Alexander
Scholarly Works
Is the Patient Protection and Affordable Care Act (ACA) bad for business? Did the countries' most prominent companies game the Securities and Exchange Commission (SEC) disclosure process to make negative political statements about ObamaCare? Immediately following the ACA's enactment on March 23, 2010, a number of companies drew scrutiny for issuing SEC filings writing off millions – and in AT&T's case, one billion dollars – against expected earnings for 2010 alone, based on a single, discrete tax-law change in the ACA. Congressional and Administration officials accused the firms of being "irresponsible" and using "big numbers to exaggerate the health reform's …